Streamline Health Stock Rating Lowered by Zacks (STRM)
Streamline Health (NASDAQ:STRM) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a note issued to investors on Tuesday, American Banking & Market News reports. They currently have a $7.80 target price on the stock. Zacks‘ price objective would suggest a potential downside of 1.76% from the stock’s previous close.
Streamline Health (NASDAQ:STRM) traded down 0.75% on Tuesday, hitting $7.94. The stock had a trading volume of 24,984 shares. Streamline Health has a 52 week low of $4.41 and a 52 week high of $7.80. The stock’s 50-day moving average is $7.26 and its 200-day moving average is $6.71. The company’s market cap is $103.3 million.
Streamline Health (NASDAQ:STRM) last released its earnings data on Monday, September 9th. The company reported ($0.07) EPS for the quarter. The company had revenue of $8.80 million for the quarter, compared to the consensus estimate of $5.05 million. On average, analysts predict that Streamline Health will post $-0.30 earnings per share for the current fiscal year.
Streamline Health Solutions, Inc (NASDAQ:STRM) is a healthcare information technology company, which is focused on developing and licensing software solutions that improve document-centric information flows and complement and enhance existing transaction-centric hospital healthcare information systems.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.